Rapp TB, Ward JP, Alaia MJ (2012) Aneurysmal bone cyst. J Am Acad Orthop Surg 20:233–241. https://doi.org/10.5435/JAAOS-20-04-233
Lange T, Stehling C, Frohlich B, Klingenhofer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jurgens H, Schulte TL (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22:1417–1422. https://doi.org/10.1007/s00586-013-2715-7
Article PubMed PubMed Central Google Scholar
Durr HR, Grahneis F, Baur-Melnyk A, Knosel T, Birkenmaier C, Jansson V, Klein A (2019) Aneurysmal bone cyst: results of an off label treatment with Denosumab. BMC Musculoskelet Disord 20:456. https://doi.org/10.1186/s12891-019-2855-y
Article CAS PubMed PubMed Central Google Scholar
Kurucu N, Akyuz C, Ergen FB, Yalcin B, Kosemehmetoglu K, Ayvaz M, Varan A, Aydin B, Kutluk T (2018) Denosumab treatment in aneurysmal bone cyst: evaluation of nine cases. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.26926
Sciot R, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Tallini G, Van den Berghe H, Vanni R, Willen H (2000) Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. a report from the CHAMP study group. Mod Pathol 13:1206–1210. https://doi.org/10.1038/modpathol.3880224
Article CAS PubMed Google Scholar
Palmerini E, Ruggieri P, Angelini A, Boriani S, Campanacci D, Milano GM, Cesari M, Paioli A, Longhi A, Abate ME, Scoccianti G, Terzi S, Trovarelli G, Franchi A, Picci P, Ferrari S, Leopardi MP, Pierini M (2018) Denosumab in patients with aneurysmal bone cysts: a case series with preliminary results. Tumori 104:344–351. https://doi.org/10.1177/0300891618784808
Article CAS PubMed PubMed Central Google Scholar
Oliveira AM, Chou MM (2014) USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45:1–11. https://doi.org/10.1016/j.humpath.2013.03.005
Article CAS PubMed Google Scholar
Park HY, Yang SK, Sheppard WL, Hegde V, Zoller SD, Nelson SD, Federman N, Bernthal NM (2016) Current management of aneurysmal bone cysts. Curr Rev Musculoskelet Med 9:435–444. https://doi.org/10.1007/s12178-016-9371-6
Article PubMed PubMed Central Google Scholar
Maximen J, Robin F, Tronchot A, Rossetti A, Ropars M, Guggenbuhl P (2022) Denosumab in the management of Aneurysmal bone cyst: a literature review. Joint Bone Spine 89:105260. https://doi.org/10.1016/j.jbspin.2021.105260
Article CAS PubMed Google Scholar
Pelle DW, Ringler JW, Peacock JD, Kampfschulte K, Scholten DJ 2nd, Davis MM, Mitchell DS, Steensma MR (2014) Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response. Transl Res 164:139–148. https://doi.org/10.1016/j.trsl.2014.03.005
Article CAS PubMed Google Scholar
Won KY, Kalil RK, Kim YW, Park YK (2011) RANK signalling in bone lesions with osteoclast-like giant cells. Pathology 43:318–321. https://doi.org/10.1097/PAT.0b013e3283463536
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay J-Y, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280. https://doi.org/10.1016/s1470-2045(10)70010-3
Article CAS PubMed Google Scholar
Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O’Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA (2018) Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. World J Surg Oncol 16:191. https://doi.org/10.1186/s12957-018-1478-3
Article PubMed PubMed Central Google Scholar
Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E (2019) Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol 20:1719–1729. https://doi.org/10.1016/S1470-2045(19)30663-1
Article CAS PubMed Google Scholar
Boyce AM (2017) Denosumab: an emerging therapy in pediatric bone disorders. Curr Osteoporos Rep 15:283–292. https://doi.org/10.1007/s11914-017-0380-1
Article PubMed PubMed Central Google Scholar
Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman T, Venkatramani R (2021) Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer 68:e28778. https://doi.org/10.1002/pbc.28778
Article CAS PubMed Google Scholar
Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine oncology study group. Spine (Phila Pa 1976) 35:E1221-1229. https://doi.org/10.1097/BRS.0b013e3181e16ae2
Vanderniet JA, Wall CL, Mullins A, London K, Lim L, Hibbert S, Briody J, Padhye B, Poon M, Biggin A, Dalla-Pozza L, Munns CF (2022) Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone 159:116395. https://doi.org/10.1016/j.bone.2022.116395
Article CAS PubMed Google Scholar
Ooi HL, Briody J, Biggin A, Cowell CT, Munns CF (2013) Intravenous zoledronic acid given every 6 months in childhood osteoporosis. Horm Res Paediatr 80:179–184. https://doi.org/10.1159/000354303
Article CAS PubMed Google Scholar
Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451–464. https://doi.org/10.1016/j.spinee.2003.07.007
Fehlings MG, Vaccaro A, Wilson JR, Singh A, Cadotte W, Harrop JS, Aarabi B, Shaffrey C, Dvorak M, Fisher C, Arnold P, Massicotte EM, Lewis S, Rampersaud R (2012) Early versus delayed decompression for traumatic cervical spinal cord injury: results of the surgical timing in acute spinal cord injury study (STASCIS). PLoS ONE 7:e32037. https://doi.org/10.1371/journal.pone.0032037
Article CAS PubMed PubMed Central Google Scholar
Wilson JR, Singh A, Craven C, Verrier MC, Drew B, Ahn H, Ford M, Fehlings MG (2012) Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord 50:840–843. https://doi.org/10.1038/sc.2012.59
Article CAS PubMed Google Scholar
Papagelopoulos PJ, Choudhury SN, Frassica FJ, Bond JR, Unni KK, Sim FH (2001) Treatment of aneurysmal bone cysts of the pelvis and sacrum. J Bone Joint Surg Am 83:1674–1681. https://doi.org/10.2106/00004623-200111000-00009
Article CAS PubMed Google Scholar
Alhumaid I, Abu-Zaid A (2019) Denosumab therapy in the management of aneurysmal bone cysts: a comprehensive literature review. Cureus 11:e3989. https://doi.org/10.7759/cureus.3989
Article PubMed PubMed Central Google Scholar
Boye K, Jebsen NL, Zaikova O, Knobel H, Londalen AM, Trovik CS, Monge OR, Hall KS (2017) Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort. Acta Oncol 56:479–483. https://doi.org/10.1080/0284186X.2016.1278305
Article CAS PubMed Google Scholar
Muheremu A, Ma Y, Huang Z, Shan H, Li Y, Niu X (2017) Diagnosing giant cell tumor of the bone using positron emission tomography/computed tomography: a retrospective study of 20 patients from a single center. Oncol Lett 14:1985–1988. https://doi.org/10.3892/ol.2017.6379
Article CAS PubMed PubMed Central Google Scholar
Hao K, Wang Q (2019) 18F-FDG PET/CT imaging in evaluation the efficacy of denosumab for giant cell tumor of bone. J Nucl Med 60:1279–1279
Pan KS, Boyce AM (2021) Denosumab treatment for giant cell tumors, aneurysmal bone cysts, and fibrous dysplasia-risks and benefits. Curr Osteoporos Rep 19:141–150. https://doi.org/10.1007/s11914-021-00657-z
Article PubMed PubMed Central Google Scholar
Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27:1462–1470. https://doi.org/10.1002/jbmr.1603
Article CAS PubMed Google Scholar
Grasemann C, Schundeln MM, Hovel M, Schweiger B, Bergmann C, Herrmann R, Wieczorek D, Zabel B, Wieland R, Hauffa BP (2013) Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget’s disease. J Clin Endocrinol Metab 98:3121–3126. https://doi.org/10.1210/jc.2013-1143
Article CAS PubMed Google Scholar
Gossai N, Hilgers MV, Polgreen LE, Greengard EG (2015) Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone. Pediatr Blood Cancer 62:1078–1080. https://doi.org/10.1002/pbc.25393
Setsu N, Kobayashi E, Asano N, Yasui N, Kawamoto H, Kawai A, Horiuchi K (2016) Severe hypercalcemia following denosumab treatment in a juvenile patient. J Bone Miner Metab 34:118–122. https://doi.org/10.1007/s00774-015-0677-z
Uday S, Gaston CL, Rogers L, Parry M, Joffe J, Pearson J, Sutton D, Grimer R, Hogler W (2018) Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumor of bone. J Clin Endocrinol Metab 103:596–603. https://doi.org/10.1210/jc.2017-02025
留言 (0)